Search Results

Containing any of the words

Only of the type

A PHASE 2A, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-06651600 AND PF 06700841 AS INDUCTION AND OPEN LABEL EXTENSION TREATMENT IN SUBJECTS WITH MODERATE TO SEVERE CROHN’S DISEASE Drug Clinical Trial

A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Arm, Parallel-Group Study in Pediatric Subjects Aged 10 Through 17 Years to Evaluate the Efficacy and Safety of BG00012 and BIIB017 for the Treatment of Relapsing-Remitting Multiple Sclerosis Drug Clinical Trial

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System Performance Clinical Trial

FDA Approves First Drug for Treating Fibromyalgia Awareness Article

New Approved Indications for Evista® Drug Reduces Risk of Invasive Breast Cancer in Postmenopausal Women Awareness Article

Long-term pain and adherence observational study for Endometriosis treatment Drug Clinical Trial

SFDA Chief Attends Arab Health Organizations Conference, Forum News

SFDA Partners with Global Leaders at IMDRF for Innovation and Harmonization in Medical Device Regulation News

SFDA Approves the Registration of Qalsody for the Treatment of Amyotrophic Lateral Sclerosis (ALS) News

Real-World Evidence for Post-Marketing Regulatory Decisions Workshop